- Home
- Automated
- List of product information
- NEODOL INJECTION 25 MG/ML [SIN09444P]
NEODOL INJECTION 25 MG/ML [SIN09444P]
Active ingredients: NEODOL INJECTION 25 MG/ML
Product Info
NEODOL INJECTION 25 MG/ML
[SIN09444P]
Product information
Active Ingredient and Strength | DICLOFENAC SODIUM - 25 MG/ML |
Dosage Form | INJECTION |
Manufacturer and Country | BROWN & BURK PHARMACEUTICAL LTD - INDIA |
Registration Number | SIN09444P |
Licence Holder | NAINA MOHAMED & SONS PRIVATE LIMITED |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | M01AB05 |
Indications: Relief of pain and inflammation in condition such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, renal colic, acute gout.
Dosage and Administration: IM dose of 75mg once daily. In severe condition, 75mg twice daily. In renal colic, a dose of 75mg repeated once after 30 minutes if necessary.
Special populations
Established cardiovascular disease or significant cardiovascular risk factors
The use of high dose diclofenac (150mg/day) for more than 4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension. If diclofenac treatment is needed, patients with established cardiovascular disease, uncontrolled hypertension or significant cardiovascular risk factors (e.g. hypertension, hyperlipidaemia, diabetes mellitus and smoking) should be treated only after careful consideration and at doses ≤ 100 mg daily when initial treatment with diclofenac injection continues with diclofenac tablets or suppositories for more than 4 weeks. As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, diclofenac should always be prescribed at the lowest effective daily dose and for the shortest duration possible.
Contraindications: Diclofenac Sodium is contraindicated in patients with history of Hypersensitivity, active peptic ulcer or Gastrointestinal bleeding, and those who are known to develop asthma, urticaria or other allergic reactions with aspirin or other NSAID's. Acute porphyria is a contraindication for Diclofenac.
The use of high dose diclofenac (150mg/day) for more than 4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension.
